Radiation and chemo for cervical cancer
Part of Cancer, Women’s health & pregnancy clinical trials.
This trial tests a shorter course of radiation combined with chemotherapy and brachytherapy (internal radiation) for cervical cancer that has not spread widely. It aims to make treatment more efficient while still being effective.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years or older.
- Your cervical cancer is stage IB, IIA, IIB, IIIA, IIIB, or a specific type of IIIC (with limited lymph node involvement).
- Your cancer is one of three common types: squamous cell, adenocarcinoma, or adenosquamous.
- You are able to receive chemotherapy with cisplatin (or carboplatin if needed) and have adequate kidney function.
- Your overall health is good enough for daily activities (ECOG score 0–2).
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a shorter course of radiation combined with chemotherapy (hypofractionated radiochemotherapy) for women with advanced cervical cancer. It may help reduce treatment time while still effectively targeting the tumor.
This trial tests a feasibility (“can it be done safely?”) approach that delivers radiation in a shorter schedule for some cervical cancer patients. It also uses weekly cisplatin chemotherapy and includes a radiation procedure called brachytherapy to improve treatment effectiveness.
This trial studies a shorter course of radiation therapy for advanced cervical cancer in women who cannot receive chemotherapy. The goal is to control the cancer and relieve symptoms with fewer treatment sessions, improving comfort and quality of life.
This trial tests a new way of delivering radiation therapy (brachytherapy) combined with chemotherapy for advanced cervical cancer. The goal is to see if a faster, more intense radiation schedule is safe and effective.
This Phase 2 trial looks at a “split” (hypo-fractionated) schedule of chemotherapy plus radiation for cervical cancer, followed by brachytherapy. It aims to see how well the treatment works and what side effects happen, especially toxicity.
This trial tests a shorter course of high-precision radiation therapy given at the same time as chemotherapy for cervical cancer that has not spread to distant organs. It aims to find if this approach is effective and safe for patients with locally advanced disease.
Hear when a new Cervical Carcinoma Stage III trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.